Home/ Stocks/ IMTX

Immatics N.V. Ordinary Shares

IMTX XNAS

$8.93 +0.88 (+10.29%) ▲ 15-min delayed

Open

$8.60

High

$9.05

Low

$8.60

Volume

611.3K

Market Cap

$1.22B

About Immatics N.V. Ordinary Shares

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Employees: 407 Website →

Earnings & Analyst Ratings

Next Earnings: Mon, Nov 16, 2026

Calendar →

Related Market News

No specific coverage for IMTX yet. Check out our latest market news or earnings calendar.

Get IMTX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Immatics N.V. Ordinary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.